Seguridad de la vacunación prenatal con Tdap y trastorno autista

REFERENCIAS

1. Gambhir M, Clark TA, Cauchemez S, Tartof SY, Swerdlow DL, Ferguson NM. A change in vaccine efficacy and duration of protection explains recent rises in pertussis incidence in the United States. PLoS Comput Biol. 2015;11(4):e1004138

2. Winter K, Glaser C, Watt J, Harriman K; Centers for Disease Control and Prevention. Pertussis epidemic–California, 2014. MMWR Morb Mortal Wkly Rep. 2014;63(48):1129–1132

3. Centers for Disease Control and Prevention. Pertussis (whooping cough). 2017. Available at: https:// www.cdc.gov/pertussis/about/signssymptoms.html. Accessed June 6, 2017

4. Centers for Disease Control and Prevention. Updated recommendations for use of tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccine (Tdap) in pregnant women and persons who have or anticipate having close contact with an infant aged <12 months — Advisory Committee on Immunization Practices (ACIP), 2011. MMWR Morb Mortal Wkly Rep. 2011;60(41):1424–1426

5. Centers for Disease Control and Prevention. Updated recommendations for use of tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis vaccine (Tdap) in pregnant women–Advisory Committee on Immunization Practices (ACIP), 2012. MMWR Morb Mortal Wkly Rep. 2013;62(7):131–135

6. Baxter R, Bartlett J, Fireman B, Lewis E, Klein NP. Effectiveness of vaccination during pregnancy to prevent infant pertussis. Pediatrics. 2017;139(5):e20164091

7. Centers for Disease Control and Prevention. Recommended immunization schedules for persons aged 0 through 18 years—United States, 2011. MMWR Morb Mortal Wkly Rep. 2011;60(5):1–4

8. Zheteyeva YA, Moro PL, Tepper NK, et al. Adverse event reports after tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis vaccines in pregnant women. Am J Obstet Gynecol. 2012;207(1):59.e1–59.e7

9. Sukumaran L, McCarthy NL, Kharbanda EO, et al. Association of Tdap vaccination with acute events and adverse birth outcomes among pregnant women with prior tetanus containing immunizations. JAMA. 2015;314(15):1581–1587

10. DeSilva M, Vazquez-Benitez G, Nordin JD, et al. Tdap vaccination during pregnancy and microcephaly and other structural birth defects in offspring. JAMA. 2016;316(17):1823–1825

11. Moro PL, Cragan J, Tepper N, et al. Enhanced surveillance of tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis (Tdap) vaccines in pregnancy in the Vaccine Adverse Event Reporting System (VAERS), 2011- 2015. Vaccine. 2016;34(20):2349–2353

12. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. 5th ed. Washington, DC: American Psychiatric Association; 2013

13. Autism and Developmental Disabilities Monitoring Network Surveillance Year 2008 Principal Investigators; Centers for Disease Control and Prevention. Prevalence of autism spectrum disorders–autism and developmental disabilities monitoring network, 14 sites, United States, 2008. MMWR Surveill Summ. 2012;61(3):1–19

14. Developmental Disabilities Monitoring Network Surveillance Year 2010 Principal Investigators; Centers for Disease Control and Prevention. Prevalence of autism spectrum disorder among children aged 8 years - autism and developmental disabilities monitoring network, 11 sites, United States, 2010. MMWR Surveill Summ. 2014;63(2):1–21

15. Courchesne E, Yeung-Courchesne R, Press GA, Hesselink JR, Jernigan TL. Hypoplasia of cerebellar vermal lobules VI and VII in autism. N Engl J Med. 1988;318(21):1349–1354

16. Gardener H, Spiegelman D, Buka SL. Prenatal risk factors for autism: comprehensive meta-analysis. Br J Psychiatry. 2009;195(1):7–14

17. Stoner R, Chow ML, Boyle MP, et al. Patches of disorganization in the neocortex of children with autism. N Engl J Med. 2014;370(13):1209–1219

18. Getahun D, Fassett MJ, Peltier MR, et al. Association of perinatal risk factors with autism spectrum disorder. Am J Perinatol. 2017;34(3):295–304

19. Hallmayer J, Cleveland S, Torres A, et al. Genetic heritability and shared environmental factors among twin pairs with autism. Arch Gen Psychiatry. 2011;68(11):1095–1102

20. Hertz-Picciotto I, Croen LA, Hansen R, Jones CR, van de Water J, Pessah IN. The CHARGE study: an epidemiologic investigation of genetic and environmental factors contributing to autism. Environ Health Perspect. 2006;114(7):1119–1125

21. Becerra TA, Wilhelm M, Olsen J, Cockburn M, Ritz B. Ambient air pollution and autism in Los Angeles county, California. Environ Health Perspect. 2013;121(3):380–386

22. American Academy of Pediatrics. Vaccine safety: examine the evidence. 2013. Available at: https://www.aap. org/en-us/Documents/immunization_ vaccine_studies.pdf. Accessed November 16, 2017 23. Stratton K, Gable A, Shetty P, McCormick M, eds; Institute of Medicine Immunization Safety Review Committee. Immunization Safety Review: Measles-Mumps-Rubella Vaccine and Autism. Washington, DC: National Academies Press; 2001

24. Hviid A, Stellfeld M, Wohlfahrt J, Melbye M. Association between thimerosal containing vaccine and autism. JAMA. 2003;290(13):1763–1766

25. Koebnick C, Langer-Gould AM, Gould MK, et al. Sociodemographic characteristics of members of a large, integrated health care system: comparison with US Census Bureau data. Perm J. 2012;16(3):37–41

26. Pasteur S. Adacel: prescribing information (tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccine, adsorbed). 2017. Available at: https://www.fda.gov/downloads/ biologicsbloodvaccines/vaccines/ approvedproducts/ucm142764.pdf. Accessed January 8, 2018 27. Luyster R, Gotham K, Guthrie W, et al. The autism diagnostic observation schedule-toddler module: a new module of a standardized diagnostic measure for autism spectrum disorders. J Autism Dev Disord. 2009;39(9):1305–1320